CMS NEWS
FOR IMMEDIATE RELEASE January 30, 2019
Contact: CMS Media
Relations
(202) 690-6145 | CMS Media Inquiries CMS proposes Medicare Advantage and Part D payment and policy updates to maximize competition and coverage
Today, the Centers for
Medicare & Medicaid Services (CMS) released proposed changes that will
take significant steps in continuing the agency’s efforts to maximize
competition among Medicare Advantage and Part D plans. These proposals will
increase plan choices and benefits and include important actions to address
the opioid crisis.
“CMS is committed to
modernizing Medicare and our top priority is to ensure that seniors have more
choices and affordable options in receiving their Medicare benefits,” said
CMS Administrator Seema Verma. “Medicare Advantage enrollment is at an
all-time high as more and more seniors are choosing to enroll in private
Medicare health and drug plans, and we need to maximize competition by
providing plans the flexibility to meet patients’ needs.”
The proposed changes will
expand opportunities for seniors to choose Medicare Advantage plans that for
the first time are providing new supplemental benefits in 2019. Beginning
with the 2019 plan year, Medicare Advantage plans can provide certain
enrollees with access to different benefits and services. For the 2020 plan
year and beyond, under statutory changes and the proposed guidance on which
we are soliciting comment in today’s release, Medicare Advantage plans will
have greater flexibility to offer chronically ill patients a broader range of
supplemental benefits that are tailored to their specific needs, such as
providing home-delivered meals or transportation for non-medical needs.
The agency is also
proposing new action to combat the nation’s opioid crisis. CMS is encouraging
Medicare Advantage plans to take advantage of new flexibilities to offer
targeted benefits and cost sharing reductions for patients with chronic pain
or undergoing addiction treatment, and encouraging Part D plans to provide
lower cost sharing for opioid-reversal agents. CMS’ overutilization policies
have resulted in a 14 percent decrease in the share of Part D beneficiaries
using opioids between 2010 and 2017 (36.3 percent to 31.3 percent), with the
largest decrease from 2016 to 2017 (5 percent).
Medicare Advantage remains
a popular choice among beneficiaries and has high satisfaction ratings.
Average Medicare Advantage and Part D premiums are at their lowest in three
years and plan choices have increased. Today’s proposals build in additional
flexibilities to continue to increase choice and competition among Medicare
health and drug plans.
For a fact sheet on the
2020 Advance Notices (Part I and Part II) and the Draft Call Letter, please
visit: https://www.cms.gov/newsroom/fact-sheets/2020-medicare-advantage-and-part-d-advance-notice-part-ii-and-draft-call-letter.
CMS released Part I of the Advance Notice on December 20, 2018.
The 2020 Advance Notices
(Part I and Part II) and Draft Call Letter may be viewed by going to: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2020Part2.pdf and
selecting “2020 Advance Notices.”
All comments on the
Advance Notices – including Part I – and Draft Call Letter must be submitted
by March 1, 2019. The final 2020 Rate Announcement will be published by
Monday, April 1, 2019.
### Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress. |
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, January 30, 2019
CMS proposes Medicare Advantage and Part D payment and policy updates to maximize competition and coverage
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment